Demulcent Eye Drops Market Report 2026

The demulcent eye drops market size has grown strongly in recent years. It will grow from $2 billion in 2025 to $2.15 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rising prevalence of dry eye syndrome, increased screen time exposure, growing aging population, expansion of over-the-counter eye care products, improved access to ophthalmic medications.

The demulcent eye drops market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing awareness of ocular surface disorders, growing demand for advanced lubricating formulations, expansion of online pharmacy distribution, rising focus on preservative-free eye care, increasing use among contact lens wearers. Major trends in the forecast period include increasing adoption of preservative-free formulations, rising demand for long-lasting lubrication solutions, growing preference for single-dose packaging, expansion of combination demulcent therapies, enhanced focus on patient comfort and compliance.

The rising prevalence of dry eye disease is expected to drive the growth of the demulcent eye drops market going forward. Dry eye disease is a condition in which the eyes produce insufficient or poor-quality tears, resulting in discomfort, visual disturbances, and potential damage to the ocular surface. The increasing occurrence of dry eye disease is largely attributed to prolonged screen time, which decreases blink frequency and destabilizes the tear film, leading to dryness and irritation. Demulcent eye drops help manage dry eye disease by forming a protective layer on the eye’s surface, reducing irritation and moisture loss, and providing soothing relief to maintain eye comfort. For example, in February 2024, according to Eyes On Eyecare, a US-based media company, dry eye was the primary clinical focus for 43.39% of practices in 2024, reflecting a 16.54% increase compared to 2023. Therefore, the rising prevalence of dry eye disease is driving growth in the demulcent eye drops market.

Key companies in the demulcent eye drops market are focusing on innovative offerings, such as preservative-free formulations, to serve consumers with sensitive eyes and minimize irritation risks. Preservative-free eye drops are artificial tears formulated without chemical preservatives, making them suitable for individuals with sensitive eyes or those who require frequent use. For instance, in September 2023, Alcon Inc., a Switzerland-based pharmaceutical and medical device company, launched Systane Hydration multi-dose preservative-free (MDPF) lubricant eye drops. The product features HydroBoost Technology, combining sodium hyaluronate and HP-Guar for enhanced hydration and protection. The preservative-free formula is housed in a multi-dose bottle with PureFlow technology, ensuring sterility without preservatives. It is designed for frequent use, provides long-lasting relief for dry and irritated eyes, and is compatible with soft contact lenses.

In July 2023, Bausch + Lomb, a US-based eye health company, acquired the Blink product line of eye and contact lens drops from Johnson & Johnson Vision for $106.5 million. Through this acquisition, Bausch + Lomb aims to expand its over-the-counter (OTC) eye care portfolio and strengthen its position in providing effective solutions for dry eye and contact lens discomfort. Johnson & Johnson, a division of Johnson & Johnson, is a US-based pharmaceutical company that manufactures demulcent eye drops under its Care One and Refresh brands.

Major companies operating in the demulcent eye drops market are Pfizer Inc., AbbVie Inc., Abbott Laboratories, Novartis AG, Sun Pharmaceutical Industries Limited, Bausch + Lomb, Cipla Ltd, Santen Pharmaceutical Co. Ltd, Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., FDC Limited, AFT Pharmaceuticals, Sentiss Pharma Pvt. Ltd., VISUfarma B.V, URSAPHARM GmbH, Thea Pharmaceuticals, OASIS Medical Inc, Entod Pharmaceuticals Ltd., Scope Ophthalmics Ltd.

North America was the largest region in the demulcent eye drops market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the demulcent eye drops market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the demulcent eye drops market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the demulcent eye drops market by increasing costs of imported pharmaceutical excipients, packaging materials, sterile filling equipment, and ophthalmic-grade polymers. Manufacturers in North America and Europe are most affected due to dependence on imported raw materials, while Asia-Pacific faces cost pressures on export-oriented production. These tariffs are raising manufacturing costs and influencing product pricing strategies. However, they are also encouraging localized sourcing of excipients, domestic formulation capabilities, and regional investment in ophthalmic drug manufacturing infrastructure.

The demulcent eye drops market research report is one of a series of new reports that provides demulcent eye drops market statistics, including demulcent eye drops industry global market size, regional shares, competitors with a demulcent eye drops market share, detailed demulcent eye drops market segments, market trends and opportunities, and any further data you may need to thrive in the demulcent eye drops industry. This demulcent eye drops market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Demulcent eye drops are lubricating solutions designed to relieve eye dryness and irritation. They contain soothing agents, such as carboxymethylcellulose or hydroxypropyl methylcellulose, which form a protective film over the eye surface. Their main purpose is to provide moisture, reduce friction, and shield the eyes from further irritation or damage.

The primary product types of demulcent eye drops include artificial tears, lubricating eye drops, allergy eye drops, and other types. Artificial tears are lubricating solutions that mimic the natural moisture of the eyes to alleviate dryness and irritation. These products are available in various formulations, including preserved eye drops, preservative-free drops, multidose bottles, single-dose units, and others. They are used to manage conditions such as dry eye syndrome, allergies, eye infections, and other ocular issues. Distribution occurs through multiple channels, including retail pharmacies, online pharmacies, and hospitals or clinics. Key end users include individuals with dry eye syndrome, post-surgical patients, contact lens wearers, people with allergies, and others.

The demulcent eye drops market consists of sales of systane ultra, sodium hyaluronate (hyaluronic acid) drops, glycerin-based eye drops, dexpanthenol eye drops, and chondroitin sulfate eye drops. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.